CLAUDIA GRIMALDI - 13 Mar 2024 Form 4 Insider Report for IGC Pharma, Inc. (IGC)

Role
Director
Signature
s/ Claudia Grimaldi
Issuer symbol
IGC
Transactions as of
13 Mar 2024
Transactions value $
$0
Form type
4
Filing time
15 Mar 2024, 21:27:00 UTC
Previous filing
28 Jun 2023
Next filing
15 May 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IGC Common Stock Options Exercise $0 +83.3K +11.9% $0.00 784K 13 Mar 2024 Direct F1
transaction IGC Common Stock Options Exercise $0 +58.3K +7.44% $0.00 842K 13 Mar 2024 Direct F2
transaction IGC Common Stock Options Exercise $0 +100K +11.87% $0.00 942K 13 Mar 2024 Direct F3
transaction IGC Common Stock Options Exercise $0 +95K +10.08% $0.00 1.04M 13 Mar 2024 Direct F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IGC Restricted Stock Units Options Exercise $0 -83.3K -100% $0.00* 0 13 Mar 2024 Common Stock 83.3K Direct F1, F5
transaction IGC Restricted Stock Units Options Exercise $0 -58.3K -50% $0.00 58.3K 13 Mar 2024 Common Stock 58.3K Direct F2, F5
transaction IGC Restricted Stock Units Options Exercise $0 -100K -33.33% $0.00 200K 13 Mar 2024 Common Stock 100K Direct F3, F5
transaction IGC Restricted Stock Units Options Exercise $0 -95K -25% $0.00 285K 13 Mar 2024 Common Stock 95K Direct F4, F5
transaction IGC Options Award $0 +360K $0.00 360K 13 Mar 2024 Common Stock 360K Direct F6
transaction IGC Options Award $0 +550K $0.00 550K 13 Mar 2024 Common Stock 550K Direct F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On July 19, 2021, the Reporting Person was granted RSUs subject to vesting equally over three years starting on March 2022.
F2 On May 25, 2022, the Reporting Person was granted RSUs subject to vesting equally over three years starting on March 2023.
F3 On June 20, 2023, the Reporting Person was granted RSUs subject to vesting equally over three years starting on March 2024.
F4 On June 20, 2023, the Reporting Person was granted RSUs subject to vesting according to specific milestones set by the Company's Board of Directors. The RSUs vest when milestones are achieved.
F5 Each restricted stock unit represents a right to receive one share of IGC common stock.
F6 On March 13, 2024, the Reporting Person was granted Options subject to vesting equally over three years starting on March 2025. The exercise price is $0.26.
F7 On March 13, 2024, the Reporting Person was granted Options subject to vesting according to specific milestones set by the Company's Board of Directors. The Options vest when milestones are achieved. The exercise price is $0.26.